Final Word - BioPharm International


Final Word

Myriad Decision Places Biotech at a Crossroads

August 1, 2010

In light of the new ruling, patent licensees may want to re-evaluate the strength of their licensed patents.

Industry Input Needed on Bioassay Standards

July 1, 2010

USP is advancing efforts to develop a guidance for evaluating bioassays.

Five Things Every Biotech Company Must Know About Biosimilars

June 1, 2010

The new US legislation will forever alter the commercial landscape for biologics.

Are You Ready for a Post-Reform World?

May 1, 2010

The industry must be prepared for the impact of the sweeping changes expected from the new legislation.

Better Times Ahead for Biotech

April 1, 2010

This year's BIO International Convention will be occurring against a backdrop of profound change in our industry.

Quality Considerations for Peptide Manufacturing Processes

March 1, 2010

As a key element in the peptide production process, quality should be built into every step.

QbD: A Roadmap to Adoption

January 1, 2010

The nimbleness of biotechs makes them well suited to implementing QbD. Here's how to get started.

Faking It

December 1, 2009

Drug counterfeiting has become a major problem for the FDA today; a variety of solutions is needed.

Apply the "Butterfly Effect" to Streamline Your Supply Chain

October 1, 2009

Small changes can have a big effect further downstream in your manufacturing processes.



Click here